scispace - formally typeset
N

Nick Andrews

Researcher at Boston Children's Hospital

Publications -  67
Citations -  3364

Nick Andrews is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Anxiogenic & Diazepam. The author has an hindex of 29, co-authored 60 publications receiving 2711 citations. Previous affiliations of Nick Andrews include Organon International & Guy's Hospital.

Papers
More filters
Journal ArticleDOI

Comparative Study of Pre- and Postsynaptic 5-HT1AReceptor Modulation of Anxiety in Two Ethological Animal Tests

TL;DR: Evidence is provided that stimulation of the presynaptic 5-HT1A receptors in the median raphénucleus results in an anxiolytic action, whereas stimulation of those of the post-synaptic 4- HT1Areceptors in its projection area of the dorsal hippocampus results in a anxiogenic effect.
Journal ArticleDOI

5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze

TL;DR: Either the two tests have different sensitivities to midazolam and 8-OH-DPAT or more intriguingly, the tests are evoking fundamentally different states of anxiety, with that evoked by the plus-maze being mediated via brain areas or receptors different from those studied here.
Journal ArticleDOI

Does age matter? The impact of rodent age on study outcomes

TL;DR: It is highlighted that choice of age is inconsistent across the research community and often not based on the development or cellular ageing of the system being studied, which could potentially result in decreased scientific validity and increased experimental variability.
Journal ArticleDOI

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety

TL;DR: In rats naive to handling, but not in handling-habituated animals, baclofen and (R,S) zacopride had significant anxiolytic effects, shown by an increased percentage of time spent on the open arms of the elevated plus-maze.
Journal ArticleDOI

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

TL;DR: The data uncover GCH1, SPR and their downstream metabolite BH4 as critical regulators of T cell biology that can be readily manipulated to either block autoimmunity or enhance anticancer immunity.